Barbara Wiggins to Treatment Outcome
This is a "connection" page, showing publications Barbara Wiggins has written about Treatment Outcome.
Connection Strength
0.300
-
Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia. J Cardiovasc Pharmacol. 2021 11 01; 78(5):e631-e640.
Score: 0.083
-
Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing = 120 Kilograms versus 60-120 Kilograms. Am J Cardiovasc Drugs. 2021 Sep; 21(5):545-551.
Score: 0.080
-
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 11 22; 134(21):e468-e495.
Score: 0.059
-
Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin. Pharmacotherapy. 2016 Feb; 36(2):e5-7.
Score: 0.056
-
Bivalirudin: a direct thrombin inhibitor for percutaneous transluminal coronary angioplasty. Pharmacotherapy. 2002 Aug; 22(8):1007-18.
Score: 0.022